ASCO LUNG Cancer Roundtable - NSCLC Trial Updates: CheckMate 9LA Opdivo and Yervoy with Chemo

dbrock's picture
Checkmate 9LA - Opdivo (Nivolumab) and Yervoy (Ipilimumab) with Chemo vs. Chemo Alone for Treatment of PD-L1 Positive Advanced Non Small Cell Lung Cancer
H. Jack West, MD, Founder, President and CEO
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.

Dr. Jack West has a virtual discussion with Helena A. Yu, MD, medical oncologist with Memorial Sloan Kettering specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.

Drs. West, Yu and Spigel discuss trial updates in non small cell lung cancer. For this video, the topic of discussion is Checkmate 9LA - Opdivo (Nivolumab) and Yervoy (Ipilimumab) with Chemo vs. Chemo Alone for Treatment of PD-L1 Positive Advanced Non Small Cell Lung Cancer

To join the conversation, visit https://cancergrace.org/forum.

Video Language: 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation